$13bn acquisition will give GlaxoSmithKline full ownership of the over-the-counter healthcare business
Novartis buckles under political and shareholder pressure and scraps payment for consulting and non-compete agreement
With several sectors’ worth of experience under his belt, Jimenez has certainly proved to be the right man for Novartis
The European CEO awards 2022 have now been announced, presenting our pick of the CEOs, companies and campaigns leading their sectors.
